BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4409279)

  • 1. [Drug permeation through synthetic lipid membranes. 5. Permeability of synthetic lecithin membranes for a group of structurally similar heterocyclics].
    Falk M; Fürst W; Hannig E; Böhm R
    Pharmazie; 1974 Aug; 29(8):542-3. PubMed ID: 4409279
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug permeation through synthetic lipoid membranes. 4. Properties and structure of lecithin-collodium-membranes].
    Falk M; Fürst W
    Pharmazie; 1974; 29(10-11):715-20. PubMed ID: 4438413
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug permeation through synthetic lipid membranes. Permeability of lecithin-collodium membranes for drugs and metabolites].
    Falk M; Fürst W
    Pharmazie; 1974 Sep; 29(9):590-3. PubMed ID: 4420510
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug permeation through synthetic lipoid membranes. 7. A resorption model with a lecithin membrane for testing the biological availability of drugs].
    Falk M; Fürst W; Lauterbach H
    Pharmazie; 1975 Dec; 30(12):775-9. PubMed ID: 3807
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drug permeation through synthetic lipoid membranes. 9. Studies on the appearance of diffusion layers in relation to membrane composition and permeating drugs].
    Lerche D; Becker R; Falk M; Fürst W
    Pharmazie; 1976 Nov; 31(11):800-4. PubMed ID: 1023248
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug permeability through artificial lipoid membranes. 1. Preparation of lecithin membranes].
    Fürst W; Falk M
    Pharmazie; 1970 Sep; 25(9):546-50. PubMed ID: 5486683
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug permeation through synthetic lipid membranes. Part 10: The effects of diffusion layers on the permeation process (author's transl)].
    Fürst W; Neubert R; Reppel L
    Pharmazie; 1980 Feb; 35(2):106-9. PubMed ID: 7384178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug permeation through synthetic lipid membranes. 12. Production of polydimethylsiloxane membranes for permeation models].
    Winter K; Richter H; Fürst W; Reppel L
    Pharmazie; 1980 Feb; 35(2):121. PubMed ID: 7384182
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug permeation through synthetic lipid membranes. Part 13: The effects of tensides on the permeation of ionized drugs (author's transl)].
    Fürst W; Neubert R; Förster B; Reppel L
    Pharmazie; 1980; 34(5-6):315-6. PubMed ID: 7413708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug permeation through synthetic lipid membranes. 11. Various membrane types used in permeation and absorption models].
    Fürst W; Neubert R; Richter H; Reppel L
    Pharmazie; 1980 Feb; 35(2):120-1. PubMed ID: 7384181
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers.
    Demina T; Grozdova I; Krylova O; Zhirnov A; Istratov V; Frey H; Kautz H; Melik-Nubarov N
    Biochemistry; 2005 Mar; 44(10):4042-54. PubMed ID: 15751981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug permeation through artificial lipoid membranes. 2. Mathematical description of substance transport].
    Falk M; Fürst W
    Pharmazie; 1973; 28(11):765-8. PubMed ID: 4791265
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
    Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeability through DOPC/dodecane membranes: measurement and LFER modelling.
    Huque FT; Box K; Platts JA; Comer J
    Eur J Pharm Sci; 2004 Nov; 23(3):223-32. PubMed ID: 15489123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR study on permeability of hydrophobic compounds with artificial membranes.
    Fujikawa M; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeation prediction of M100240 using the parallel artificial membrane permeability assay.
    Hwang KK; Martin NE; Jiang L; Zhu C
    J Pharm Pharm Sci; 2003; 6(3):315-20. PubMed ID: 14738711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The permeation of organic acids through lecithin bilayers. Resemblance to diffusion in polymers.
    Wolosin JM; Ginsburg H
    Biochim Biophys Acta; 1975 Apr; 389(1):20-33. PubMed ID: 237547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug permeation through synthetic lipoid membranes. 18. The mechanism of ion-pair permeation proton countertransport].
    Neubert R; Fürst W; Schleiermacher H
    Pharmazie; 1985 Jun; 40(6):426-7. PubMed ID: 4034654
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipid composition effect on permeability across PAMPA.
    Seo PR; Teksin ZS; Kao JP; Polli JE
    Eur J Pharm Sci; 2006 Nov; 29(3-4):259-68. PubMed ID: 16781125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy.
    Venturelli A; Tondi D; Cancian L; Morandi F; Cannazza G; Segatore B; Prati F; Amicosante G; Shoichet BK; Costi MP
    J Med Chem; 2007 Nov; 50(23):5644-54. PubMed ID: 17956081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.